Flagellin Polypeptide-Based Solutions for Niche Environments

This inventive concept adapts Enterococcus gallinarum flagellin polypeptides for specialized applications in high-security, disaster relief, extreme weather, remote area, and high-density population settings, offering targeted solutions for infectious disease treatment and prevention.

The original patent disclosed pharmaceutical compositions comprising Enterococcus flagellin polypeptides for general disease treatment. However, these compositions may not be suitable for specific, demanding environments. This inventive concept addresses the need for tailored solutions in niche markets, ensuring effective disease management in unique operational contexts.

The new claims describe systems, methods, and compositions that combine Enterococcus gallinarum flagellin polypeptides with specialized formulations, packaging, and delivery mechanisms. For instance, Claim 1 presents a system for treating infectious diseases in high-security environments, featuring a tamper-evident container. Claim 2 discloses a method for stimulating an immune response in subjects exposed to extreme weather conditions, using a heat-stable formulation. Claim 3 describes a pharmaceutical composition for disaster relief, packaged in a portable, waterproof container. Claim 4 presents a kit for treating infectious diseases in remote areas, with a sterile water vial and syringe. Claim 5 outlines a system for preventing infectious diseases in high-density populations, utilizing a portable, battery-powered nebulizer for nasal administration.

The new claims introduce novel combinations of Enterococcus gallinarum flagellin polypeptides with specialized components and delivery mechanisms, tailored to specific niche environments. These adaptations provide non-obvious solutions that address the limitations of the original patent in these unique contexts.

Other potential implementations of the inventive concept could include formulations for veterinary use, combination therapies with other immunomodulators, or integration with wearable devices for real-time monitoring and treatment.

The inventive concept has significant commercial potential in various industries, including biodefense, disaster response, extreme weather preparedness, and population health management. Target markets may include government agencies, non-governmental organizations, and private companies operating in these specialized areas.